معرفی
Jonas Larsson is a Professor and Research team manager at the Division of Molecular Medicine and Gene Therapy, Faculty of Medicine, Lund University. He also serves as Deputy dean at the Faculty of Medicine, and holds principal investigator positions at both the Lund University Cancer Centre (LUCC) and StemTherapy: National Initiative on Stem Cells for Regenerative Therapy. Additionally, he is a Professor at the WCMM-Wallenberg Centre for Molecular Medicine. His extensive academic roles demonstrate his significant leadership and research contributions across multiple prestigious institutions within Lund University.
Dr. Larsson's research focuses on hematopoietic stem cell biology, gene therapy, and molecular medicine. His work spans cancer research, regenerative medicine, stem cell differentiation, and blood cell formation. He employs cutting-edge techniques including CRISPR/Cas9 gene targeting and RNA interference to investigate fundamental mechanisms governing stem cell behavior. His research has important implications for understanding hematopoietic disorders and developing novel therapeutic approaches for blood-related diseases and cancers.
Analysis of his publication record reveals a strong emphasis on hematopoietic stem cell dynamics during regeneration, molecular mechanisms of blood cell formation, and therapeutic applications of gene editing technologies. His research spans both basic science investigations of stem cell biology and translational work with clinical applications, particularly in the areas of leukemia and stem cell transplantation.
Dr. Larsson actively supervises multiple PhD students and leads several major research projects including 'Enhancing blood stem cell transplantation using a nanotechnology-based RNA delivery system' and 'Deciphering mechanisms regulating renewal and differentiation of hematopoietic stem cells.' His collaborative work extends across international boundaries as indicated by his external collaborations.
His laboratory work is centered around the Division of Molecular Medicine and Gene Therapy at Lund University, with additional affiliations at the Lund University Cancer Centre and StemTherapy initiative. These positions provide him with comprehensive resources for conducting cutting-edge research in stem cell biology and molecular medicine across multiple collaborative platforms.
